RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors
Clinical trial NCT06546150 · RECRUITING
Trial details
- NCT number
- NCT06546150
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.